Home › Targets › CTLA4-Ig

CTLA4-Ig (1 companies · 2 programs)

Companies with an active program directed at CTLA4-Ig.

Coya Therapeutics, Inc. COYA

COYA 302 — Amyotrophic Lateral Sclerosis Phase 2
COYA 302 — Frontotemporal Dementia Phase 1